In addition, there is a positive correlation between the levels of Escherichia/Shigella and pro-inflammatory cytokines IL-1β and CXCL2 in the serum of patients with AD, suggesting that alteration of these gut microbiota taxa is possibly associated with peripheral inflammation in patients with AD [189]. Here, CXCL2 is linked to Alzheimer disease.